| 000 | 01052 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250512091033.0 | ||
| 264 | 0 | _c19730323 | |
| 008 | 197303s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(73)90118-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShaw, K M | |
| 245 | 0 | 0 |
_aMelatonin and parkinsonism. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cFeb 1973 |
||
| 300 |
_a271 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelatonin _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 | _aPlacebos |
| 700 | 1 | _aStern, G M | |
| 700 | 1 | _aSandler, M | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 7797 _gp. 271 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(73)90118-9 _zAvailable from publisher's website |
| 999 |
_c4125049 _d4125049 |
||